<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vsp</journal-id><journal-title-group><journal-title xml:lang="ru">Вопросы современной педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Current Pediatrics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-5527</issn><issn pub-type="epub">1682-5535</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">vsp-1277</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>БЕЗОПАСНОСТЬ И ЭФФЕКТИВНОСТЬ ИНАКТИВИРОВАННОЙ СУБЪЕДИНИЧНОЙ ГРИППОЗНОЙ ВАКЦИНЫ ПРИ МАССОВОЙ ВАКЦИНАЦИИ ДЕТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>SAFETY AND EFFICIENCY OF INACTIVATED OF SUBUNIT INFLUENZA VACCINE AT MASS VACCINATION OF CHILDREN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гендон</surname><given-names>Ю.З.</given-names></name><name name-style="western" xml:lang="en"><surname>Gendon</surname><given-names>Yu.Z.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ вакцин и сывороток им. И.И. Мечникова РАМН, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Mechnikov Research Institute of vaccines and serums, Russian Academy of Medical Sciences, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>21</day><month>10</month><year>2015</year></pub-date><volume>6</volume><issue>5</issue><issue-title>Вопросы современной педиатрии</issue-title><fpage>42</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Гендон Ю., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Гендон Ю.</copyright-holder><copyright-holder xml:lang="en">Gendon Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vsp.spr-journal.ru/jour/article/view/1277">https://vsp.spr-journal.ru/jour/article/view/1277</self-uri><abstract/><trans-abstract xml:lang="en"/></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">WHO. Influenza vaccines. WHO position paper. Weekly Epid. Rec. 2005; 80: 279–287.</mixed-citation><mixed-citation xml:lang="en">WHO. Influenza vaccines. WHO position paper. Weekly Epid. Rec. 2005; 80: 279–287.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Гендон Ю.З. Проблемы профилактики гриппа у маленьких детей. Вопросы вирусологии. 2006; 2: 4–9.</mixed-citation><mixed-citation xml:lang="en">Гендон Ю.З. Проблемы профилактики гриппа у маленьких детей. Вопросы вирусологии. 2006; 2: 4–9.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Izarieta A. Thompson W., Kramar P. et al. Influenza and the rate of hospitalization for respiratory diseases among infant and young children. N. Engl. Med. J. 2000; 342: 232–239.</mixed-citation><mixed-citation xml:lang="en">Izarieta A. Thompson W., Kramar P. et al. Influenza and the rate of hospitalization for respiratory diseases among infant and young children. N. Engl. Med. J. 2000; 342: 232–239.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Neuzil K., Zhu Y., Griffin M. et al. Burden or interpandemic infenza in children younger than 5 years: a 95-years prospective study. J. Infect. Dis. 2002; 185: 147–152.</mixed-citation><mixed-citation xml:lang="en">Neuzil K., Zhu Y., Griffin M. et al. Burden or interpandemic infenza in children younger than 5 years: a 95-years prospective study. J. Infect. Dis. 2002; 185: 147–152.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Glezen W. Morbidity associated with respiratory viruses. Pediatr. Ann. 1990; 19: 535–542.</mixed-citation><mixed-citation xml:lang="en">Glezen W. Morbidity associated with respiratory viruses. Pediatr. Ann. 1990; 19: 535–542.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Committee on influenza disease. Recommendation for influenza immunization of children. Pediatrics. 2004; 113: 1441–1447.</mixed-citation><mixed-citation xml:lang="en">Committee on influenza disease. Recommendation for influenza immunization of children. Pediatrics. 2004; 113: 1441–1447.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Гендон Ю.З. Вакцины и химиопрепараты для профилактики гриппа. Вопросы вирусологии. 2007; 1: 4–10.</mixed-citation><mixed-citation xml:lang="en">Гендон Ю.З. Вакцины и химиопрепараты для профилактики гриппа. Вопросы вирусологии. 2007; 1: 4–10.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wood J., Williams M. History of inactivated influenza vaccines. In: Textbook of Influenza. Ed. Nocholson K., Webster R., Hay A. Oxford: Blackwell Sci. 1998. 317–323.</mixed-citation><mixed-citation xml:lang="en">Wood J., Williams M. History of inactivated influenza vaccines. In: Textbook of Influenza. Ed. Nocholson K., Webster R., Hay A. Oxford: Blackwell Sci. 1998. 317–323.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beyer W., Palache A., Osterhaus A. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. Clin. Drug. Invest. 1998; 15: 1–12.</mixed-citation><mixed-citation xml:lang="en">Beyer W., Palache A., Osterhaus A. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines. Clin. Drug. Invest. 1998; 15: 1–12.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Beyer W., Palache A., de Jong J. et al. Cold – adapted vaccine versu inactivated vaccine: systemic vaccine reactions, local and systemic antibody respons and vaccine efficacy. A meta-analysis. Vaccine. 2002; 20: 1340–1353.</mixed-citation><mixed-citation xml:lang="en">Beyer W., Palache A., de Jong J. et al. Cold – adapted vaccine versu inactivated vaccine: systemic vaccine reactions, local and systemic antibody respons and vaccine efficacy. A meta-analysis. Vaccine. 2002; 20: 1340–1353.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Palache A., Nanta J., de Rey V. et al. Twenty years’ experience with the safety and immenogenicity or an inactivated subunit influenca vaccine. J. Drug Asess. 2005; 8: 1–15.</mixed-citation><mixed-citation xml:lang="en">Palache A., Nanta J., de Rey V. et al. Twenty years’ experience with the safety and immenogenicity or an inactivated subunit influenca vaccine. J. Drug Asess. 2005; 8: 1–15.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lin Y. Recent change among human influenza virus. Virus Res. 2004, 103: 47–52.</mixed-citation><mixed-citation xml:lang="en">Lin Y. Recent change among human influenza virus. Virus Res. 2004, 103: 47–52.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chendon Y., Kaira A., Elshina E. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elder. Epidemiol. Infect. 2006; 134: 71–78.</mixed-citation><mixed-citation xml:lang="en">Chendon Y., Kaira A., Elshina E. The effect of mass influenza immunization in children on the morbidity of the unvaccinated elder. Epidemiol. Infect. 2006; 134: 71–78.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
